These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36967448)

  • 21. Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study.
    Mathis T; Papegaey M; Ricard C; Rezkallah A; Matonti F; Sudhalkar A; Vartin C; Dot C; Kodjikian L
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VISUAL OUTCOMES IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT IN ROUTINE CLINICAL PRACTICE.
    Urbančič M; Gardašević Topčić I; Matović K
    Acta Clin Croat; 2021 Dec; 60(4):602-608. PubMed ID: 35734494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region.
    Wei W; Chen Y; Hu B; Zhao M; Han M; Dai H; Uy HS; Chen MY; Wang K; Jiao J; Lou J; Li XY
    Clin Ophthalmol; 2021; 15():4097-4108. PubMed ID: 34675477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema.
    Callanan DG; Gupta S; Boyer DS; Ciulla TA; Singer MA; Kuppermann BD; Liu CC; Li XY; Hollander DA; Schiffman RM; Whitcup SM;
    Ophthalmology; 2013 Sep; 120(9):1843-51. PubMed ID: 23706947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone implant for refractory macular edema secondary to diabetic retinopathy and retinal vein occlusion.
    Zhong YY; Tang C; Zhang LY; Zhang XD; Liu SL
    Int J Ophthalmol; 2024; 17(10):1837-1842. PubMed ID: 39430031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dexamethasone intravitreal implant for refractory and treatment-naive diabetic macular edema in Taiwanese patients.
    Wang JK; Huang TL; Hsu YR; Chang PY
    J Chin Med Assoc; 2021 Mar; 84(3):326-330. PubMed ID: 33433135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study.
    Rosenblatt A; Udaondo P; Cunha-Vaz J; Sivaprasad S; Bandello F; Lanzetta P; Kodjikian L; Goldstein M; Habot-Wilner Z; Loewenstein A;
    Ophthalmology; 2020 Mar; 127(3):377-393. PubMed ID: 31932090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal Dexamethasone Implant in Patients Who Did Not Complete Anti-VEGF Loading Dose During the COVID-19 Pandemic: a Retrospective Observational Study.
    Scorcia V; Giannaccare G; Gatti V; Vaccaro S; Piccoli G; Villì A; Toro MD; Yu AC; Iovino C; Simonelli F; Carnevali A
    Ophthalmol Ther; 2021 Dec; 10(4):1015-1024. PubMed ID: 34482532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal dexamethasone implant Ozurdex in the treatment of diabetic macular edema in patients not previously treated with any intravitreal drug: a prospective 12-month follow-up study.
    Menezo M; Roca M; Menezo V; Pascual I
    Curr Med Res Opin; 2019 Dec; 35(12):2111-2116. PubMed ID: 31378087
    [No Abstract]   [Full Text] [Related]  

  • 31. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
    Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex
    Udaondo P; Hervas-Ontiveros A; Rosemblatt A; Garcia-Delpech S
    Clin Ophthalmol; 2021; 15():4153-4162. PubMed ID: 34703201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes.
    Özdemir HB; Hasanreisoğlu M; Yüksel M; Ertop M; Gürelik G; Özdek Ş
    Turk J Ophthalmol; 2019 Dec; 49(6):323-327. PubMed ID: 31893587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of diabetic macular edema and factors predicting outcomes in sham-treated patients (MEAD study).
    Yoon YH; Boyer DS; Maturi RK; Bandello F; Belfort R; Augustin AJ; Li XY; Bai Z; Hashad Y;
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2639-2653. PubMed ID: 31654188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Early efficacy of dexamethasone implant (OZURDEX
    Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2017 May; 40(5):408-413. PubMed ID: 28336283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of diabetic macular edema with intravitreal DEX Implant in Germany: Efficacy and safety in naïve and pre-treated patients in clinical practice.
    Augustin AJ
    Eur J Ophthalmol; 2022 Nov; 32(6):3609-3614. PubMed ID: 35345914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes of Taiwanese patients with treatment-naïve diabetic macular edema.
    Wang JK; Huang TL; Chang PY
    J Formos Med Assoc; 2020 Nov; 119(11):1619-1625. PubMed ID: 32482606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
    Ozsaygili C; Duru N
    Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Analysis of Intravitreal Dexamethasone Implant (Ozurdex) and Brolucizumab Injection in the Treatment of Diabetic Macular Edema with Hyperreflective Intraretinal Dots: A Retrospective Study.
    Chakraborty S; Sheth JU
    Clin Ophthalmol; 2024; 18():2897-2905. PubMed ID: 39429440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal dexamethasone implant in naïve and previously treated patients with diabetic macular edema: a retrospective study.
    Medina-Baena M; Cejudo-Corbalán O; García-Pulido JI; Huertos-Carrillo MJ; Girela-López E
    Int J Ophthalmol; 2020; 13(10):1597-1605. PubMed ID: 33078111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.